Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: Design, synthesis, and pharmacological characterization

Paola Conti; Andrea Pinto; Lucia Tamborini; Ulf Madsen; Birgitte Nielsen; Hans Bräuner-Osborne; Kasper Bø Hansen; Elisa Landucci; Domenico E Pellegrini-Giampietro; Giovambattista De Sarro; Eugenio Donato Di Paola; Carlo De Micheli

doi:10.1002/cmdc.201000184

Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: Design, synthesis, and pharmacological characterization

Paola Conti, Andrea Pinto, Lucia Tamborini, Ulf Madsen, Birgitte Nielsen, Hans Bräuner-Osborne, Kasper Bø Hansen, Elisa Landucci, Domenico E Pellegrini-Giampietro, Giovambattista De Sarro, Eugenio Donato Di Paola, Carlo De Micheli

18 Citations (Scopus)

Abstract

The design and synthesis of new N1-substituted 3-carboxyand 3-phosphonopyrazoline and pyrazole amino acids that target the glutamate binding site of NMDA receptors are described. An analysis of the stereochemical requirements for high-affinity interaction with these receptors was performed. We identified two highly potent and selective competitive NMDA receptor antagonists, (5S,αR)-1 and (5S,αR)-4, which exhibit good in vitro neuroprotective activity and in vivo anticonvulsant activity by i.p. administration, suggesting that these molecules may have potential use as therapeutic agents.

Original language	English
Journal	ChemMedChem
Volume	5
Issue number	9
Pages (from-to)	1465-1475
ISSN	1860-7179
DOIs	https://doi.org/10.1002/cmdc.201000184
Publication status	Published - 3 Sept 2010

Keywords

Former Faculty of Pharmaceutical Sciences

Access to Document

10.1002/cmdc.201000184

Cite this

Conti, P., Pinto, A., Tamborini, L., Madsen, U., Nielsen, B., Bräuner-Osborne, H., Hansen, K. B., Landucci, E., Pellegrini-Giampietro, D. E., De Sarro, G., Donato Di Paola, E., & De Micheli, C. (2010). Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: Design, synthesis, and pharmacological characterization. ChemMedChem, 5(9), 1465-1475. https://doi.org/10.1002/cmdc.201000184

Conti, P, Pinto, A, Tamborini, L, Madsen, U , Nielsen, B , Bräuner-Osborne, H, Hansen, KB, Landucci, E, Pellegrini-Giampietro, DE, De Sarro, G, Donato Di Paola, E & De Micheli, C 2010, 'Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: Design, synthesis, and pharmacological characterization', ChemMedChem, vol. 5, no. 9, pp. 1465-1475. https://doi.org/10.1002/cmdc.201000184

@article{259b5f00b4f911df825b000ea68e967b,

title = "Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: Design, synthesis, and pharmacological characterization",

abstract = "The design and synthesis of new N1-substituted 3-carboxyand 3-phosphonopyrazoline and pyrazole amino acids that target the glutamate binding site of NMDA receptors are described. An analysis of the stereochemical requirements for high-affinity interaction with these receptors was performed. We identified two highly potent and selective competitive NMDA receptor antagonists, (5S,αR)-1 and (5S,αR)-4, which exhibit good in vitro neuroprotective activity and in vivo anticonvulsant activity by i.p. administration, suggesting that these molecules may have potential use as therapeutic agents.",

keywords = "Former Faculty of Pharmaceutical Sciences",

author = "Paola Conti and Andrea Pinto and Lucia Tamborini and Ulf Madsen and Birgitte Nielsen and Hans Br{\"a}uner-Osborne and Hansen, {Kasper B{\o}} and Elisa Landucci and Pellegrini-Giampietro, {Domenico E} and {De Sarro}, Giovambattista and {Donato Di Paola}, Eugenio and {De Micheli}, Carlo",

year = "2010",

month = sep,

day = "3",

doi = "10.1002/cmdc.201000184",

language = "English",

volume = "5",

pages = "1465--1475",

journal = "Farmaco, Edizione Pratica",

issn = "1860-7179",

publisher = "Wiley - V C H Verlag GmbH & Co. KGaA",

number = "9",

}

TY - JOUR

T1 - Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists

T2 - Design, synthesis, and pharmacological characterization

AU - Conti, Paola

AU - Pinto, Andrea

AU - Tamborini, Lucia

AU - Madsen, Ulf

AU - Nielsen, Birgitte

AU - Bräuner-Osborne, Hans

AU - Hansen, Kasper Bø

AU - Landucci, Elisa

AU - Pellegrini-Giampietro, Domenico E

AU - De Sarro, Giovambattista

AU - Donato Di Paola, Eugenio

AU - De Micheli, Carlo

PY - 2010/9/3

Y1 - 2010/9/3

N2 - The design and synthesis of new N1-substituted 3-carboxyand 3-phosphonopyrazoline and pyrazole amino acids that target the glutamate binding site of NMDA receptors are described. An analysis of the stereochemical requirements for high-affinity interaction with these receptors was performed. We identified two highly potent and selective competitive NMDA receptor antagonists, (5S,αR)-1 and (5S,αR)-4, which exhibit good in vitro neuroprotective activity and in vivo anticonvulsant activity by i.p. administration, suggesting that these molecules may have potential use as therapeutic agents.

AB - The design and synthesis of new N1-substituted 3-carboxyand 3-phosphonopyrazoline and pyrazole amino acids that target the glutamate binding site of NMDA receptors are described. An analysis of the stereochemical requirements for high-affinity interaction with these receptors was performed. We identified two highly potent and selective competitive NMDA receptor antagonists, (5S,αR)-1 and (5S,αR)-4, which exhibit good in vitro neuroprotective activity and in vivo anticonvulsant activity by i.p. administration, suggesting that these molecules may have potential use as therapeutic agents.

KW - Former Faculty of Pharmaceutical Sciences

U2 - 10.1002/cmdc.201000184

DO - 10.1002/cmdc.201000184

M3 - Journal article

C2 - 20665761

SN - 1860-7179

VL - 5

SP - 1465

EP - 1475

JO - Farmaco, Edizione Pratica

JF - Farmaco, Edizione Pratica

IS - 9

ER -

Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: Design, synthesis, and pharmacological characterization

Abstract

Keywords

Access to Document

Fingerprint

Cite this